(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 84.01% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.9%, and it is also forecast to beat the US market's average forecast revenue growth rate of 23.1%.
Prenetics Global's revenue in 2026 is $107,762,000.On average, 5 Wall Street analysts forecast PRE's revenue for 2026 to be $3,367,474,797, with the lowest PRE revenue forecast at $3,130,567,876, and the highest PRE revenue forecast at $3,771,490,256.
In 2027, PRE is forecast to generate $5,258,484,523 in revenue, with the lowest revenue forecast at $4,869,413,730 and the highest revenue forecast at $5,734,675,926.